Johnson & Johnson acquires Israeli robotics company, further boosting their med-tech ambitions
Key Insights and Signals – Hospital & Healthcare
Centre setup and expansion Mayo Clinic begins orthopedics, neurosurgery at facility getting UD 4.5 Mn renovation The project adds a third operating room and three private pre- and postoperative patient rooms, and renovates two operating rooms. Along with neurosurgery and orthopedics, the increased capacity comes with facial and plastic surgery offerings and robotic surgery tech for general surgery and OB-GYN services. Read More>> ProHealth Care announces opening date of new Mukwonago hospital The project has involved building out new space and renovating existing space at its D.N. Greenwald Center campus to convert it into a 24-inpatient bed hospital. Services will include a 24/7 emergency department, inpatient and outpatient surgical services, advanced diagnostic imaging, primary and specialty care, a cancer center, physical and occupational therapy, and a retail pharmacy. Read More>>Executive Movement Genesis Healthcare announces sweeping leadership, operational changes The company will replace most of its corporate leadership team and change its operational model as it continues to focus on its recovery. As the company continues to seek a replacement for its top executive, it is bringing on four new corporate-level leaders to support the rapid implementation of a market-focused model and a 100-day plan to grow revenue, reduce costs, and streamline the decision-making process. Read More>> LifeLabs appoints Jennifer Cudlipp as Chief Operating Officer Jennifer has been a part of the LifeLabs leadership team for several years and has an extensive understanding of the business as a whole. As COO, Jennifer will be accountable for all areas of operations at LifeLabs including lab operations, client services, supply chain, employee health and safety and environmental sustainability, logistics and specimen management and more. Read More>>Deals Prisma Health, United Healthcare sign a deal The multi-year contract ensures UnitedHealthcare members uninterrupted access to all Prisma hospitals, facilities and physicians. A UnitedHealthcare spokesperson said the final contract is consistent with the previously agreed-upon terms from last month, according to WYFF. Read More>> Wellcare signs agreement with Prospect Medical in Texas As part of the agreement, Wellcare’s Medicare Advantage members will now have in-network access to Prospect Medical providers and facilities in the San Antonio metro area. Through its Coordinated Care Model, Prospect Medical providers offer innovative, high-quality, cost-effective care. Read More>>Mergers and Acquisitions Cravath, Baker McKenzie to lead Johnson & Johnson spinoff Cravath and Baker McKenzie have named multiple partners across their M&A, tax, intellectual property, and executive compensation practices to lead the spinoff effort. Johnson & Johnson will spin off its consumer products division from its drug and medical device businesses in the next 18 to 24 months citing growth, agility, and consumer needs. Read More>> MedLife confirms ongoing takeover of OncoCard Hospital in Brasov The transaction will be analyzed by the Competition Council and could become MedLife Group’s second-largest transaction in 2021, after Neolife’s approval. The discussions for this acquisition were initiated at the end of 2019 but were postponed in the context of the Covid-19 pandemic and resumed this year. Read More>>Partnerships ECU and Vidant Health join forces to improve health care in rural North Carolina Under the agreement, the Brody School of Medicine and Vidant Health will remain separate legal entities but will function collaboratively as ECU Health starting Jan. 1, 2022. The goal is to become a national academic model for providing rural health care. Read More>> Intermountain Healthcare plans drone prescription deliveries Electric drone maker Zipline announced its partnership with Intermountain. The company’s fleet is capable of flying in any weather condition and can drop packages from the sky with a parachute to the area of a few parking spaces. It claims to have made over 200,000 successful deliveries by air. Read More>>
Key Insights and Signals in Pharmaceutical
New Centre setup and Expansion AstraZeneca continues to grow footprint in China with landmark expansion AstraZeneca is not only focusing on its own innovative products and solutions but is also placing significant emphasis on partnership and the industry as a whole. As AstraZeneca returns to the China International Import Expo, it is seeking to help further expand the influence of the important event and contribute to building up an integrated healthcare service ecosystem. Read More>> Catalent’s USD 230 Mn expansion of US gene therapy plant The latest investment at contract development manufacturing organization (CDMO) Catalent’s Harmans campus includes the construction of three additional multi-room commercial suites, as well as expanding storage capabilities for ultra-low temperature freezers, just-in-time inventory space, and its water-for-injection infrastructure. Read More>>Deals AstraZeneca to sell COVID-19 vaccine for profit – after saving one million lives Drug-maker AstraZeneca has signed its first deals to sell the COVID-19 vaccine developed with Oxford University for profit, having supplied more than 1.5 Bn doses worldwide at cost price. It said consultations with medical experts suggest coronavirus will move into an epidemic phase in the coming months, with future outbreaks starting to become contained to specific countries. Read More>> South Korea secures 60 Mn Pfizer vaccine doses for 2022 The deal is a follow-up to an earlier deal signed in August that secured 30 Mn doses and had an option for an additional 30 million doses. The contract is part of South Korea’s plan to secure enough vaccine doses to cover the first shots of the country’s 52 million people next year. Read More>>Partnerships Ironwood Pharmaceuticals collaborates with Cour Pharmaceuticals The agreement gives Ironwood an option to acquire an exclusive license to develop and commercialize, in the U.S., COUR’s investigational therapy. The therapy could transform the treatment of Primary Biliary Cholangitis – a rare autoimmune disease targeting the liver that can lead to irreversible damage and scarring of the liver tissue. Read More>> AbbVie and UChicago extend collaboration to support Preclinical Oncology Research The collaboration has led to novel insights related to biomarkers and therapeutic applications for existing AbbVie programs. This has included the development of novel drug delivery approaches to enhance anti-tumor immune response and incorporating unique 3D screening methodologies for selecting novel therapeutic molecules. Read More>>Mergers and Acquisition GE to spin off GE Healthcare in early 2023 The spinoff marks the end of the conglomerate’s 129 years as a whole company. The company is looking forward to simplifying its business, reducing debt, and improving its share price. GE Healthcare will be spun off in early 2023, followed by GE Renewable Energy and Power in early 2024, leaving GE singularly focused on aviation. Read More>>Executive Movement Charles River Laboratories promotes Birgit Girshick to COO In her new role as Executive VP and Chief Operating Officer, Ms. Girshick will add oversight of the Research Models and Services business, at which she began her Charles River career in 1989. Read More>>
Key Insights and Signals in Medical Devices
New Centre setup and Expansion Arthrex is investing USD 100M in Anderson County expansion This investment will help Arthrex better support the growth and development of new and innovative products that help surgeons treat their patients better and will create over 500 new jobs. The expansion includes a second manufacturing plant and an electron beam and x-ray sterilization facility. Read More>>Deal and Deal Renewal Coloplast inks USD 2.5 Bn deal with Linklaters-Led PE Firm to acquire Atos Medical The deal to buy Atos Medical would bring Coloplast A/S access to a new chronic care business. Closing of the transaction is subject to customary regulatory approvals and is anticipated in Q2 2021/22. Read More>>Partnerships Omnicell inks new deal to manage controlled substances This collaboration will combine Omnicell’s Controlled Substance Dispenser (CSD) automation workflow with Fresenius Kabi Simplist MicroVault pre-filled syringes to offer healthcare providers advanced tools and technology for safe and efficient dispensing of controlled substances. Read More>> Siemens Healthineers, UCSF team up to build carbon-neutral imaging tech Siemens’ and UCSF’s approach aims to reach carbon neutrality by first reducing the amount of energy consumed during radiology procedures—which have required massive amounts of power to conduct each scan—then issuing renewable energy certificates to offset the remainder. Read More>>Mergers and Acquisition J&J and Globus Medical ink acquisitions for robotics Synthes GMBH, Johnson & Johnson orthopedics company, acquired Israel-based robotics company OrthoSpin for USD 79.5 Mn. Globus Medical acquired Capstone Surgical Technologies, a company that developed a surgical drill that uses oscillating technology for bone removal, disk removal and screw insertion in minimally invasive spine surgery. Read More>> Mirion Technologies acquires CHP Dosimetry The acquisition closed on Nov. 1, 2021. Headquartered in Clinton, Tenn., CHP Dosimetry provides dosimetry services for medical practices, veterinary offices, universities, and government agencies, as well as industrial and environmental companies. Read More>> Globus Medical eyes acquisition of spinal implant maker NuVasive Globus Medical Inc has approached NuVasive Inc with an acquisition offer of an undisclosed amount. The potential combination would accelerate consolidation in the spine surgery market, where smaller players are turning to deal making to compete against the stronger players like Johnson & Johnson, Medtronic Plc, and Zimmer Biomet Holdings Inc. Read More>>Executive Movement Bioventus announces CFO transition plan Greg Anglum is transitioning from his role as Senior Vice President and Chief Financial Officer (CFO) to pursue other career opportunities. To ensure a smooth transition, Mr. Anglum will remain in his current role until a successor is named. Mr. Anglum’s departure is unrelated to Bioventus’ business performance, financial reporting, or controls. Read More>> Johnson & Johnson announces Jessica Moore as VP of Investor Relations Ms. Moore brings 20 years of diverse and international financial experience spanning across Sales Operations, Corporate and Regional positions. Ms. Moore will report to Mr. Joseph Wolk, Executive Vice President and Chief Financial Officer of the Company. Read More>>
Did you find the newsletter helpful? *|SURVEY: Yes|* *|SURVEY: No|*
Latest Industry Insights from Draup Braindesk
Medical device companies in Europe are proactive in offering solutions to address the demands of diagnostic equipment and wound care products.
Cybersecurity and Data Security of connected devices and systems used have increased across the Industry. Digital technology is now becoming infused in every sector of healthcare delivery.
Medical device companies in Europe are trying to offer solutions to address the demands of the aging population.
3D medical printing is expected to develop and implement in several segments of the medical industry.
Baxter announces USD 100 Mn Investment in BioPharma Solutions Halle/Westfalen, Germany Sterile Fill/Finish Manufacturing Facility
This strategic investment will expand the BPS manufacturing footprint and add state-of-the-art equipment designed to help products achieve stability and improved shelf life through lyophilization (freeze drying). Construction will also add an aseptic syringe filling line, enabling BPS to meet the growing demand for this delivery platform in both Europe and the United States. Read More>>
Company – Beacon Total Funding– USD 29.85 Mn About: Beacon’s goal is to improve human health by applying artificial intelligence to brain activity. Beacon Biosignals delivered EEG reports with unprecedented speed and accuracy, eliminating adjudication with enhanced inclusion/exclusion criteria. Read More>>
Latest Reports Published in Draup
Mundipharma Account Intelligence Report: Mundipharma focuses on enhancing its Clinical Development & Trials capabilities using advanced technologies to improve remote patient monitoring and provide personalized clinical care service worldwide. Read More>>
Merck Account Intelligence Report: The company is keen to develop its human healthcare segment through the cardiovascular pipeline, maternal care, and treatment for autoimmune diseases & fatty liver problem. Read More>>
Here’s what’s new on our Sales Intelligence Platform Add Multiple Lists in My Leads
Introducing capability to add multiple lists in My Leads to help you manage different outreaches effectively
Introducing Academic Ecosystem analysis in Ecosystem for a location selection
Added LGBTQ Inclusive Policies Index in Ecosystem’s location analysis to help you examine a location’s law and policies towards LGBTQ people
Now, you can export all the account profile sections default view data in one click